18.93
[1]. Khan S, et al. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat Med. 2019 Dec;25():1938-19.
P261-P26-P20-P21-P280-P302+P352-P30+P30-P330-P362+P36-P05-P501
GHS0
![]()